Dynavax (DVAX) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
Research and development: 23.23M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
Research and development: 23.23M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Dynavax (NASDAQ: DVAX) reported Q2 EPS of ($0.63), in-line with the analyst estimate of ($0.63). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.62 million.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Credo Technology shares rise on analyst support and conference comments
- Jefferies Starts DBS Group Holdings (DBS:SP) (DBSDY) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
